[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341161-105":59,"doc-detail-341161-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","sox13-is-a-novel-prognostic-biomarker-and-associates-with-immune-infiltration-in-breast-cancer","SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer","","Study evaluates SOX13 as a prognostic biomarker in breast cancer and clarifies its links with immune infiltration and the tumor microenvironment. Survival, expression, and genomic evidence were assessed using public resources (UNLCAL, GEPIA, TIMER, Kaplan–Meier plotter), while clinical relevance was validated by immunohistochemistry. Gene alterations were obtained from cBioportal, co-expression and regulators from LinkedOmics, and immune infiltration from ImmuCellAI and TIMER2.0; drug sensitivity was analyzed with GDSC2. Results show higher SOX13 associates with worse overall survival, immune infiltration patterns, and drug resistance.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sox13-is-a-novel-prognostic-biomarker-and-associates-with-immune-infiltration-in-breast-cancer/341161/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sox13-is-a-novel-prognostic-biomarker-and-associates-with-immune-infiltration-in-breast-cancer/341161.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What is SOX13 in this study, and why is it investigated in breast cancer?","Question",{"text":113,"@type":114},"SOX13 is a transcription factor within the SOX family. The study investigates its biological and clinical implications because SOX proteins are important in cancer progression, while SOX13’s role in breast cancer had been little known.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was SOX13’s prognostic value assessed?",{"text":118,"@type":114},"Survival and expression patterns were evaluated using databases including UNLCAL, GEPIA, TIMER, and Kaplan–Meier plotter. Cox analysis was used to test whether SOX13 independently predicted poor overall survival, and immunohistochemistry supported findings in clinical specimens.",{"name":120,"@type":111,"acceptedAnswer":121},"What associations did the study find between SOX13 and the tumor microenvironment or immune cells?",{"text":122,"@type":114},"Higher SOX13 expression correlated with tumor microenvironment features and with diverse infiltration levels of immune cells, evaluated through ImmuCellAI and TIMER2.0-based immune infiltration analyses.",{"name":124,"@type":111,"acceptedAnswer":125},"How does SOX13 relate to drug resistance in breast cancer according to the study?",{"text":126,"@type":114},"Drug sensitivity analysis using the GDSC2 database indicated that higher SOX13 expression predicts higher IC50 values for many drugs, supporting an association with drug resistance.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},341161,1790182083,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","TYPE Original Research PUBLISHED 19 April 2024  \nDOI 10.3389/fimmu.2024.1369892  \nOPEN ACCESS  \nEDITED BY Yuan Li,  \nShandong University, China  \nREVIEWED BY  \nXiongbin Kang,  \nBielefeld University, Germany Dan Chen,  \nSalk Institute for Biological Studies, United States  \nYong Zhang,  \nThe Second Afﬁliated Hospital of Xi’an Jiaotong University, China  \n*CORRESPONDENCE Yuehua Li  \n [liyuehua2020@stu.usc.edu.cn](liyuehua2020@stu.usc.edu.cn)[ ](liyuehua2020@stu.usc.edu.cn)Liming Xie  \n[xlmusc@163.com](xlmusc@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 13 January 2024  \nACCEPTED 05 April 2024  \nPUBLISHED 19 April 2024  \nCITATION  \nGao T, Jiang B, Zhou Y, He R, Xie L and Li Y (2024) SOX13 is a novel prognostic biomarker and associates with immune inﬁltration in breast cancer.  \nFront. Immunol. 15:1369892 .  \ndoi: 10.3389/fimmu.2024.1369892  \nCOPYRIGHT  \n© 2024 Gao, Jiang, Zhou, He, Xie and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nSOX13 is a novel prognostic biomarker and associates with immune inﬁltration in breast cancer  \nTing Gao 1,2†, Baohong Jiang 1†, Yu Zhou 1, Rongfang He 1, Liming Xie 1* and Yuehua Li 1*  \n1The First Afﬁliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China, 2The First Afﬁliated Hospital of Guangxi Medical University, Nanning, China  \nBackground: The transcription factor, SOX13 is part of the SOX family. SOX proteins are crucial in the progression of many cancers, and some correlate with carcinogenesis. Nonetheless, the biological and clinical implications of SOX13 inhuman breast cancer (BC) remain rarely known.  \nMethods: We evaluated the survival and expression data of SOX13 in BC patients via the UNLCAL, GEPIA, TIMER, and Kaplan-Meier plotter databases. Immunohistochemistry (IHC) was used to verify clinical specimens. The gene alteration rates of SOX13 were acquired on the online web cBioportal. With the aid of the TCGA data, the association between SOX13 mRNA expression and copy number alterations (CNA) and methylation was determined. LinkedOmics was used to identify the genes that co-expressed with SOX13 and the regulators. Immune inﬁltration and tumor microenvironment evaluations were assessed by ImmuCellAI and TIMER2 . 0 databases. SOX13 correlated drug resistance analysis was performed using the GDSC2 database.  \nResults: Higher SOX13 expression was discovered in BC tissues in comparison to normal tissues. Moreover, increased gene mutation and ampliﬁcation of SOX13 were found in BC. Patients with increased SOX13 expression levels showed worse overall survival (OS) . Cox analysis showed that SOX13 independently served as a prognostic indicator for poor survival in BC. Further, the expression of SOX13 was also conﬁrmed to be correlated with tumor microenvironment and diverse inﬁltration of immune cells. In terms of drug sensitivity analysis, we found higher expression level of SOX13 predicts a high IC50 value for most of 198 drugs which predicts drug resistance.  \nConclusion: The present ﬁndings demonstrated that high expression of SOX13 negatively relates to prognosis and SOX13 plays an important role in cancer immunity. Therefore, SOX13 may potentially be adopted as a biomarker for predicting BC prognosis and inﬁltration of immune cells.  \nKEYWORDS  \nSOX13, prognosis, breast cancer, immunohistochemistry, bioinformatics analysis  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nBreast cancer (BC) is the most common malignant tumor in women. According to the global cancer data in 2020, there we","cbCaiagCnox9zTwA","https://ap.wps.com/l/cbCaiagCnox9zTwA","pdf",9118803,"English","# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What is SOX13 in this study, and why is it investigated in breast cancer?\",\"answer\":\"SOX13 is a transcription factor within the SOX family. The study investigates its biological and clinical implications because SOX proteins are important in cancer progression, while SOX13’s role in breast cancer had been little known.\"},{\"question\":\"How was SOX13’s prognostic value assessed?\",\"answer\":\"Survival and expression patterns were evaluated using databases including UNLCAL, GEPIA, TIMER, and Kaplan–Meier plotter. Cox analysis was used to test whether SOX13 independently predicted poor overall survival, and immunohistochemistry supported findings in clinical specimens.\"},{\"question\":\"What associations did the study find between SOX13 and the tumor microenvironment or immune cells?\",\"answer\":\"Higher SOX13 expression correlated with tumor microenvironment features and with diverse infiltration levels of immune cells, evaluated through ImmuCellAI and TIMER2.0-based immune infiltration analyses.\"},{\"question\":\"How does SOX13 relate to drug resistance in breast cancer according to the study?\",\"answer\":\"Drug sensitivity analysis using the GDSC2 database indicated that higher SOX13 expression predicts higher IC50 values for many drugs, supporting an association with drug resistance.\"}]","SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer | PDF",1790040645,35,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3ec7dd2f2f4d1d8ed002c893c80b6ab.webp",983,1389,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7a8c1117e8dbb4b45ca3619c88a4ed8.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/466e271c5d2a237e06413aeb06445bea.webp",981,1386,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6aa4be763219bc4eadd5ba4072a8f560.webp",980,1385]